Atlas Pharmaceuticals, Inc.
Records under this name other than patents Atlas Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Atlas Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,333,309 | Human-derived glycoprotein, biologically active factor which includes glycoprotein, and pharmaceutical product which comprises biologically active factor as active component Lapsed on the fee record Ended Dec 25, 2013 · USPTO record | Lapsed on the fee record | Ended Dec 25, 2013 | USPTO record |
| US 6,306,827 | Method for preventing and/or treating renal disease Lapsed on the fee record Ended Oct 23, 2013 · USPTO record | Lapsed on the fee record | Ended Oct 23, 2013 | USPTO record |
| US 7,306,791 | Agent for preventing and/or treating multiple organ failure Lapsed on the fee record Ended Dec 11, 2011 · USPTO record | Lapsed on the fee record | Ended Dec 11, 2011 | USPTO record |
| US 7,138,372 | Agent for preventing and/or treating cachexia Lapsed on the fee record Ended Nov 21, 2010 · USPTO record | Lapsed on the fee record | Ended Nov 21, 2010 | USPTO record |
| US 7,115,568 | Methods using TCF II Lapsed on the fee record Ended Oct 3, 2010 · USPTO record | Lapsed on the fee record | Ended Oct 3, 2010 | USPTO record |
| US 6,399,744 | TCF mutant Lapsed on the fee record Ended Jun 4, 2010 · USPTO record | Lapsed on the fee record | Ended Jun 4, 2010 | USPTO record |
| US 5,328,836 | Plasmids containing DNA encoding the amino acid sequence of TCF-II and use thereof Term ended Term ended no later than Jul 12, 2014 · Low confidence | Term ended | Term ended no later than Jul 12, 2014 | Low confidence |
| US 5,510,327 | Highly concentrated TCF pharmaceutical preparations Term ended Term ended no later than Apr 23, 2016 · Low confidence | Term ended | Term ended no later than Apr 23, 2016 | Low confidence |
| US 5,587,359 | Human derived glycoprotein, biologically active factor which includes glycoprotein and pharmaceutical product Term ended Term ended no later than Dec 24, 2016 · Low confidence | Term ended | Term ended no later than Dec 24, 2016 | Low confidence |
| US 5,658,742 | Monoclonal antibody Term ended Term ended no later than Aug 19, 2017 · Low confidence | Term ended | Term ended no later than Aug 19, 2017 | Low confidence |